Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 434, 1035-1040 (21 April 2005) | doi:10.1038/nature03547; Received 18 February 2005; Accepted 14 March 2005; Published online 6 April 2005
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
nature jobs
System Engineer (Simulation and Modelling)
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Post Doctoral Research Associate
- University of Illinois
- Urbana United States
Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction
Kenya Honda1,4, Yusuke Ohba1,2,4, Hideyuki Yanai1,4, Hideo Negishi1, Tatsuaki Mizutani1, Akinori Takaoka1, Choji Taya3 & Tadatsugu Taniguchi1
- Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan
- Information and Cell Function, PRESTO, JST, Kawaguchi, Saitama 332-0012, Japan
- Department of Laboratory Animal Science, Tokyo Metropolitan Institute of Medical Science, Honkomagome 3-18-22, Bunkyo-ku, Tokyo 113-8613, Japan
- These authors contributed equally to this work
Correspondence to: Tadatsugu Taniguchi1 Correspondence and requests for materials should be addressed to T.T. (Email: tada@m.u-tokyo.ac.jp).
Abstract
Robust type-I interferon (IFN-
/
) induction in plasmacytoid dendritic cells, through the activation of Toll-like receptor 9 (TLR9), constitutes a critical aspect of immunity1, 2, 3, 4, 5, 6. It is absolutely dependent on the transcription factor IRF-7, which interacts with and is activated by the adaptor MyD88. How plasmacytoid dendritic cells, but not other cell types (such as conventional dendritic cells), are able to activate the MyD88–IRF-7-dependent IFN induction pathway remains unknown. Here we show that the spatiotemporal regulation of MyD88–IRF-7 signalling is critical for a high-level IFN induction in response to TLR9 activation. The IFN-inducing TLR9 ligand, A/D-type CpG oligodeoxynucleotide (CpG-A)3, 4, 8, 9, 10, 11, is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the MyD88–IRF-7 complex. However, in conventional dendritic cells, CpG-A is rapidly transferred to lysosomal vesicles. We further show that conventional dendritic cells can also mount a robust IFN induction if CpG-A is manipulated for endosomal retention using a cationic lipid. This strategy also allows us to demonstrate endosomal activation of the IFN pathway by the otherwise inactive TLR9 ligand B/K-type oligodeoxynucleotide (CpG-B)3, 4, 8, 9, 10, 11, 12. Thus, our study offers insights into the regulation of TLR9 signalling in space, potentially suggesting a new avenue for therapeutic intervention.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
IRF-7 is the master regulator of type-I interferon-dependent immune responsesNature Letters to Editor (07 Apr 2005)
Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cellsNature Immunology Article (01 May 2006)
Activation of the mammalian immune system by siRNAsNature Biotechnology Research (01 Nov 2005)
See all 30 matches for Research
